| Patrice Evans Counseling, Pllc | |
|
N3936 W Lost Lake Rd Wetmore MI 49895-9581 | |
| (906) 387-6404 | |
| Not Available |
| Full Name | Patrice Evans Counseling, Pllc |
|---|---|
| Speciality | Counselor |
| Location | N3936 W Lost Lake Rd, Wetmore, Michigan |
| Authorized Official Name and Position | Patrice Maree Evans (CLINICAL SOCIAL WORKER) |
| Authorized Official Contact | 9063876404 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Patrice Evans Counseling, Pllc Po Box 435 Munising MI 49862-0435 Ph: (906) 387-6404 | Patrice Evans Counseling, Pllc N3936 W Lost Lake Rd Wetmore MI 49895-9581 Ph: (906) 387-6404 |
| NPI Number | 1225313067 |
|---|---|
| Provider Enumeration Date | 10/12/2011 |
| Last Update Date | 02/06/2022 |
| Certification Date | 02/06/2022 |
| Medicare PECOS PAC ID | 2062687635 |
|---|---|
| Medicare Enrollment ID | O20111209000048 |
News Archive
Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.
Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr. Von Hoff, an oncologist and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center, is known worldwide for his groundbreaking cancer research.
Millions of people have reduced their dependence on eyeglasses and contact lenses over the past several years with the refractive surgery procedure known as LASIK. This procedure can correct refractive errors such as nearsightedness, farsightedness and astigmatism.
More than 14-million Americans, with chronic or life altering diseases and cancer, can't afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That's why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225313067 | NPI | - | NPPES |
| 1639364706 | Other | MI | INDIVIDUAL NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 680185455 (Michigan) | Primary |
| Provider Name | Patrice M Evans |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1639364706 PECOS PAC ID: 4082780036 Enrollment ID: I20080827000733 |
News Archive
Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.
Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr. Von Hoff, an oncologist and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center, is known worldwide for his groundbreaking cancer research.
Millions of people have reduced their dependence on eyeglasses and contact lenses over the past several years with the refractive surgery procedure known as LASIK. This procedure can correct refractive errors such as nearsightedness, farsightedness and astigmatism.
More than 14-million Americans, with chronic or life altering diseases and cancer, can't afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That's why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.
› Verified 7 days ago
News Archive
Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.
Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr. Von Hoff, an oncologist and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center, is known worldwide for his groundbreaking cancer research.
Millions of people have reduced their dependence on eyeglasses and contact lenses over the past several years with the refractive surgery procedure known as LASIK. This procedure can correct refractive errors such as nearsightedness, farsightedness and astigmatism.
More than 14-million Americans, with chronic or life altering diseases and cancer, can't afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That's why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.
› Verified 7 days ago